Diversity, Equity & Inclusion Summit 2021 has ended
Back To Schedule
Wednesday, November 10 • 11:30am - 12:00pm
Fireside Chat with Michael Petroutsas, Senior Vice President, Head of US Oncology Business Unit at GSK: How Inclusive Communications are Central to Creating a Better Cancer Care System for the Future

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

The pandemic has caused people to postpone or altogether skip visits to the doctor, often delaying the diagnosis of health issues and drastically impacting cancer care. Recent data published in JAMA underscores this impact: New diagnoses of eight common cancer types declined significantly from the start of the pandemic through March 2021.

Underserved populations and women have felt this impact disproportionately. To better support diverse populations during this time – regardless of race or ethnicity, gender, age or income – healthcare and pharma organizations have had to adapt. This has included hastening digital transformation efforts and changing the ways they communicate with – and provide support – to different populations.

In this fireside chat, Michael Petroutsas, Senior Vice President and Head of U.S. Oncology at GSK, will offer a firsthand look into:
  • The delays in early cancer diagnoses and initiation of treatment the pandemic caused, particularly for people in underserved populations and women
  • The urgent work left to do in not just getting people back to care – but also re-making cancer care to better serve all populations
  • The importance of tailoring patient communications to reach diverse audiences
  • How GSK leads with empathy, viewing those with cancer as people first and patients second

avatar for Michael Petroutsas, R. Ph.

Michael Petroutsas, R. Ph.

Senior Vice President, US Oncology Business Unit, GSK
Michael Petroutsas is a senior commercial leader with more than 20 years’ experience successfully leading strategic and operational teams in geographies around the globe. Michael joined GSK in February 2019. He leads the commercialization of the company’s growing oncology portfolio... Read More →

Wednesday November 10, 2021 11:30am - 12:00pm EST